134 results
Page 2 of 7
6-K
EX-10.2
x5d 48a02
21 Sep 22
Current report (foreign)
8:00am
424B5
xtv8snt
20 Sep 22
Prospectus supplement for primary offering
4:30pm
6-K
EX-99
60cwhw70l2e kr12o
19 Sep 22
BioLineRx Announces $15 Million Registered Direct Offering
8:08am
6-K
EX-99
zqw1n
15 Sep 22
Current report (foreign)
8:39am
6-K
EX-99
yknt5zvb
27 May 22
2022 Annual General Meeting of Shareholders
4:30pm
6-K
EX-10.1
8vsxztrpj qbz
3 Sep 21
Current report (foreign)
4:30pm
424B5
ivu ir4xlfeusic2st
3 Sep 21
Prospectus supplement for primary offering
4:29pm
POS AM
mle klcj2t
23 Feb 21
Prospectus update (post-effective amendment)
9:12am
6-K
EX-99
plbzc 0aqzlprh11
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
peblk
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99.2
fn4in kqw
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99
rzsmyh
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
6-K
EX-99.1
4zrmpqrznhj7u5tbq3
21 Jan 21
Amended and Restated Underwriting Agreement
4:32pm
424B5
tdi0jef
21 Jan 21
Prospectus supplement for primary offering
4:31pm
FWP
dznn8c6zsn6dwijxaj9w
19 Jan 21
Free writing prospectus
9:46pm
FWP
ktkue1c8w46l38t
19 Jan 21
Free writing prospectus
5:01pm
424B5
zi4qdz
19 Jan 21
Prospectus supplement for primary offering
5:00pm